Abiopharma

Tonix Pharmaceuticals Announces Positive Minutes from Type C FDA Meeting to Discuss Adaptive Phase 2 Field Study of TNX-4800, a Human, anti-OspA Monoclonal Antibody, to Prevent Lyme Disease in the U.S.

X-energy, SGL Carbon Announce Capacity Expansion for Nuclear-Grade Graphite

Can-Fite Launches First Clinical Program for Piclidenoson in the Rare Genetic Disease Lowe Syndrome

Cocrystal Pharma Announces $5 Million Private Placement with OPKO Health

Can-Fite Launches First Clinical Program for Piclidenoson in the Rare Genetic Disease Lowe Syndrome

Second Quarter 2026 Resultsate Report

Ocular Therapeutix™ Reports Second Quarter 2026 Financial Results and Business Highlights

Marex Group Limited completes acquisition of equity derivatives market maker Webb Traders

Smartkem, Inc. and Ferrox Critical Minerals to Combine in All-Stock Merger Valuing Ferrox at $125 Million

Wayfair Enters Pennsylvania Market with New Pittsburgh Store